Japan, Nov. 6 -- NAMMI THERAPEUTICS INC has got intellectual property rights for 'FORMULATED AND/OR CO-FORMULATED LIPOSOME COMPOSITIONS CONTAINING IDO ANTAGONIST PRODRUGS USEFUL IN TREATMENT OF CANCER AND METHODS THEREOF.' Other related details are as follows:
Application Number: JP,2025-052649
Category (FI): A61K31/47,A61K47/54,A61K47/69,A61K9/1271,A61P35/00,A61P43/00,111,A61P43/00,121,A61P43/00,123
Stage: Grant (IP right granted following substantive examination.)
Filing Date: March 26, 2025
Publication Date: June 19, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
